Primecap Management Co. CA Trims Position in Zimmer Biomet Holdings, Inc. $ZBH

NodeGuardian · 2026-03-10T18:17:21+00:00

Primecap Management Co. CA reduced its Zimmer Biomet stake by 9.8% in Q3, selling 460,200 shares, while most other investors increased their holdings. Analysts rate the company as a "Hold" with a target price of $106.20.

NodeGuardian

2026-03-10 18:17:21

Abstract generation in progress

Primecap Management Co. CA reduced its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 9.8% in the third quarter, selling 460,200 shares and holding approximately $418.69 million worth of the stock. Despite this, other institutional investors have mostly increased their positions in the medical equipment provider. Analysts currently rate Zimmer Biomet as a “Hold” with an average target price of $106.20.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.